Anesthetic approaches in carotid body tumor surgery

OBJECTIVE: Carotid body tumors (CBT) are benign tumors that originate from neural non-chromaffin cells that are typically localized near carotid bifurcation. Surgical removal of the tumor is the most appropriate treatment. General anesthesia is preferred anesthetic technique for CBT surgery. Basic elements of anesthetic management are protection of hemodynamic stability and maintaining cerebral perfusion pressure (CPP). The aim of this study was to evaluate anesthetic management of CBT surgery and present the literature knowledge. METHODS: The study included 10 consecutive patients with diagnosis of CBT who underwent surgery at Antalya Training and Research Hospital, in Antalya, Turkey, between 2013 and 2016. Preoperative demographic details; comorbidities; side of surgical site; duration of operation; length of intensive care unit (ICU) and hospital stay; change of intraoperative blood pressure; use of inotropic drugs, blood products, and analgesics; postoperative visual analogue scale (VAS) pain score; and complications were recorded. RESULTS: According to Shamblin classification, 3 tumors were type I and the remaining 7 were type II. Tumors were located on right side in 6 patients, and on left in 4. Blood loss sufficient to require transfusion was observed in 1 patient. Average intraoperative blood loss was 287±68 mL. Tachycardia and hypertension were observed in 1 patient; bradycardia and hypotension were seen in 4 patients. Infusion for inotropic support was administered to 1 patient. Mean duration of operation was 109±20 minutes. Mean VAS score was 4±1, mean ICU tramadol consumption was 80±25 mg. Duration of stay in ICU and hospital were 2.4±1.1 hours and 3.8±0.7 days, respectively. Mortality and neurological complications were not seen in postoperative period. CONCLUSION: CBT surgery requires close and complex anesthesia management. Protection of hemodynamic stability against sudden hemodynamic changes, monitoring, and maintaining CPP are the most important aspects of anesthetic management.

[1]  Wen He,et al.  Color Doppler Ultrasound in Diagnosis and Assessment of Carotid Body Tumors: Comparison with Computed Tomography Angiography. , 2016, Ultrasound in medicine & biology.

[2]  M. Persky,et al.  Treatment of Head and Neck Paragangliomas. , 2016, Cancer control : journal of the Moffitt Cancer Center.

[3]  G. Çakmak,et al.  Comparison of Combined (Deep and Superficial) and Intermediate Cervical Plexus Block by Use of Ultrasound Guidance for Carotid Endarterectomy. , 2016, Journal of cardiothoracic and vascular anesthesia.

[4]  Jian Li,et al.  Monitoring cerebral ischemia during carotid endarterectomy and stenting , 2016, Journal of biomedical research.

[5]  G. Schneider,et al.  Intraoperative Multimodal Evoked Potential Monitoring During Carotid Endarterectomy: A Retrospective Study of 264 Patients , 2015, Anesthesia and analgesia.

[6]  F. Toktaş,et al.  Protective surgical procedures for carotid body tumors: a case series. , 2014 .

[7]  L. del Guercio,et al.  Carotid and Vagal Body Paragangliomas , 2013, Translational medicine @ UniSa.

[8]  S. Kopp,et al.  Cerebral monitors versus regional anesthesia to detect cerebral ischemia in patients undergoing carotid endarterectomy: a meta-analysis , 2013, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[9]  M. Aksun,et al.  Diagnosis and management of carotid body tumor: a report of seven cases , 2013 .

[10]  I. Mader,et al.  Head and neck paragangliomas: clinical and molecular genetic classification , 2012, Clinics.

[11]  L. Pedrini,et al.  Is Near-Infrared Spectroscopy a Reliable Method to Evaluate Clamping Ischemia during Carotid Surgery? , 2011, Stroke research and treatment.

[12]  M. Gleeson,et al.  Classification and management of cervical paragangliomas. , 2011, Annals of the Royal College of Surgeons of England.

[13]  P. Bénit,et al.  SDHA is a tumor suppressor gene causing paraganglioma. , 2010, Human molecular genetics.

[14]  Chris Whiten,et al.  Carotid endarterectomy: Intraoperative monitoring of cerebral perfusion , 2009 .

[15]  A. Giatromanolaki,et al.  Carotid body tumor in a 13-year-old child: Case report and review of the literature. , 2008, Journal of vascular surgery.

[16]  M. Sajid,et al.  A multicenter review of carotid body tumour management. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[17]  T. Yin,et al.  [Diagnosis and surgical treatment of the carotid body tumors]. , 2007, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery.

[18]  M. Stoneham,et al.  Continuous cervical plexus block for carotid body tumour excision in a patient with Eisenmenger's syndrome , 2006, Anaesthesia.

[19]  K. Calligaro,et al.  Correlation of carotid artery stump pressure and neurologic changes during 474 carotid endarterectomies performed in awake patients. , 2005, Journal of vascular surgery.

[20]  A. Carvalho,et al.  Surgical treatment of paragangliomas of the carotid bifurcation: Results of 36 patients , 2004, Head & neck.

[21]  N. Ellison.  Anesthesia and Co-Existing Disease, 4th Edition , 2003 .

[22]  N. D. Kien,et al.  Cerebral protection with thiopentone during combined carotid endarterectomy and clipping of intracranial aneurysm. , 2002, Anaesthesia and intensive care.

[23]  Paul E. Stanton,et al.  Carotid endarterectomy , 1995, Transient Ischemic Attack and Stroke.

[24]  S. Sheps,et al.  Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. , 1971, American journal of surgery.

[25]  K. Luna-Ortiz,et al.  Does Shamblin’s classification predict postoperative morbidity in carotid body tumors? A proposal to modify Shamblin’s classification , 2006, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[26]  F. Moll,et al.  Transcranial Doppler Monitoring after Carotid Endarterectomy , 2005, Annals of vascular surgery.

[27]  W. Sweet,et al.  Diseases of the nervous system. , 1956, Annual review of medicine.